SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP
Raised
$1M
Investors
2
Min Invest
$112,730
AltStreet Analysis
·Generated from EDGAR primary sources
Seroba Life Sciences Fund IV Limited Partnership is an Ireland-domiciled pooled investment fund that filed under Rule 506(b) and Section 3(c)(1) on 2023-10-26. The fund reported $1.0M raised from 2 investors with a minimum investment of $113K. This is a standalone filing with no matched parent platform in the AltStreet database.
This fund follows the typical exemption pattern for private investment vehicles—506(b) for capital formation and 3(c)(1) for Investment Company Act exclusion. The $113K minimum investment is accessible relative to many institutional alternative funds, though the offshore Ireland domicile suggests a cross-border structure common in life sciences venture investing.
Data Flags
Critical Disclosures
What the filings and the regulators have said about this entity that a reader should know first. Each line links to its source. The history, the same event across other issuers, and alerts are in the terminal.
Reporting lapsed · Form D · last filing October 26, 2023
Offering declared to continue beyond a year; annual amendment 13+ months overdue An issuer that stops filing is the case the going-concern flag cannot catch: the report that would have carried it was never filed.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
dark
Investor
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
N/A SEROBA LIFE SCIENCES (GP IV) LIMITED
Executive Officer, Director · DUBLIN 2, L2
N/A SEROBA LIFE SCIENCES MANAGEMENT LIMITED
Executive Officer · DUBLIN 2, L2
PETER SANDYS
Director · DUBLIN 2, L2
ALAN O'CONNELL
Director · DUBLIN 2, L2
DANIEL O'MAHONY
Director · DUBLIN 2, L2
BRUNO MONTANARI
Director · DUBLIN 2, L2
ANDREW DUIGNAN
Executive Officer, Director · DUBLIN 2, L2
JENNIFER MCMAHON
Director · DUBLIN 2, L2
Questions About SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP?
SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP is a Ireland limited partnership that filed a Form D with the SEC on October 26, 2023 as a venture capital fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(1) for an offering of pooled investment fund interests.
Is SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP legit?
AltStreet does not rate legitimacy; it reports the public record. SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP filed a Form D with the SEC on October 26, 2023 claiming Rule 506(b), Section 3(c), Section 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $1,014,570 sold to 2 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP claimed Rule 506(b), Section 3(c), Section 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP raised?
SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP reported $1,014,570 sold from 2 investors in an offering of indefinite size as of the Form D filed October 26, 2023.
Who can invest in SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $112,730.
What is the minimum investment in SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP?
The Form D lists $112,730 as the minimum investment accepted from any outside investor as of October 26, 2023. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly.
Who is behind SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP?
The Form D lists 8 related persons: SEROBA LIFE SCIENCES (GP IV) LIMITED, executive officer, director (GENERAL PARTNER OF ISSUER); SEROBA LIFE SCIENCES MANAGEMENT LIMITED, executive officer; PETER SANDYS, director; ALAN O'CONNELL, director; DANIEL O'MAHONY, director; BRUNO MONTANARI, director; ANDREW DUIGNAN, executive officer, director; JENNIFER MCMAHON, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP located?
The issuer's address on its SEC filings is C/O Seroba Life Sciences (Gp Iv) Limited, Mount Herbert Ct, 34 Upper Mount St, Dublin 2, Ireland D02 FT72. Its phone number of record is 353 (0)1 633 4028. It is organized under the laws of Ireland.
How long is the SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP offering open?
The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.
How large is SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.